FDA Adverse Event Injury Summary report: N

MONOFOCAL IOLS

MDR report key: 2621724 · Received June 19, 2012

Report

Report Number
2648035-2012-00149
Event Type
Injury
Date Received
June 19, 2012
Date of Event
May 1, 2012
Report Date
May 20, 2012
Manufacturer
ABBOTT MEDICAL OPTICS
Product Code
HQL
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
SC, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL INFORMATION: DIABETES, BRAND NAME: PHACOFLEX II, COMMON DEVICE NAME: HQL-MONOFOCAL IOL. MODEL # S130NB, CATALOG # S130NB, SERIAL # (B)(4), EXPIRATION DATE = 06/30/1999, IMPLANT DATE: 09/19/1994, DEVICE MFR DATE: 06/01/1994, PMA# = P880081. ALL PERTINENT INFORMATION AVAILABLE TO ABBOTT MEDICAL OPTICS HAS BEEN SUBMITTED. SHOULD NEW INFORMATION BE RECEIVED THAT CHANGES THE FACTS AND/OR CONCLUSION OF THIS REPORT, ANOTHER SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative · 1

BECAUSE THE MODEL AND SERIAL NUMBER OF THE LENS IS UNKNOWN, THE SPECIFIC INFORMATION OF BRAND, TYPE, MODEL, SERIAL NUMBER, 510(K) NUMBER, MANUFACTURE AND EXPIRATION DATES CANNOT BE IDENTIFIED AT THIS TIME. ALL PERTINENT INFORMATION AVAILABLE TO ABBOTT MEDICAL OPTICS HAS BEEN SUBMITTED. SHOULD NEW INFORMATION BE RECEIVED THAT CHANGES THE FACTS AND/OR CONCLUSION OF THIS REPORT A SUPPLEMENTAL REPORT WILL BE SUBMITTED. PLACEHOLDER.

Description of Event or Problem · 1

IT IS REPORTED THAT THE INTRAOCULAR LENS (IOL) WAS REMOVED AND REPLACED DUE TO CALCIFICATION AND THE PATIENT'S REPORT OF BLURRED VISION. FOLLOW UP WITH THE REPORTING PHYSICIAN'S OFFICE INDICATES THAT THE PATIENT REQUIRED AN ANTERIOR VITRECTOMY ATTRIBUTED TO HIS ANATOMY AND NOT RELATED TO THE ABBOTT MEDICAL OPTICS (AMO) LENS. THE PATIENT IS REPORTED TO BE DOING FINE. FOLLOW-UP WITH THE PHYSICIAN INDICATED THAT THE LENS IS BELIEVED TO BE A SILICONE LENS; HOWEVER, THE MODEL AND SERIAL NUMBER IS UNKNOWN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 MONOFOCAL IOLS HQL ABBOTT MEDICAL OPTICS

Patients

Seq Age Sex Outcome Treatment
1 84 YR Required Intervention